The neuromuscular junction (NMJ) is the chemical synapse between a motor neuron's axon terminal and the muscle fibre it commands — acetylcholine released from vesicles across a 50-nanometre cleft, binding postsynaptic nicotinic receptors, and depolarising the muscle to its action potential. Safety factor 2–5×: the NMJ is built to never fail — one nerve impulse, one contraction. Its antibody diseases (myasthenia gravis at the postsynaptic receptor, Lambert-Eaton at the presynaptic calcium channel) and the anaesthetist's neuromuscular blockers all act at this one synapse.
Presynaptic active zones (voltage-gated Ca2+ channels), synaptic cleft with acetylcholinesterase, junctional folds with nicotinic receptors
Main Connections
Motor-axon terminal in; muscle-fibre sarcolemma out (the end-plate potential)
Chief Neurotransmitters
Acetylcholine (the only transmitter); acetylcholinesterase for its removal
Primary Role
One-to-one excitation from nerve to muscle
Structure & Location
Junctional folds amplify the receptor surface — the receptors clustered at the fold's mouth by agrin-MuSK-rapsyn organisation, the NMJ's self-assembly program.
Each motor axon branches to tens to thousands of fibres — the motor unit; the NMJ sits at each fibre's midpoint for uniform spread.
Synaptic basal lamina anchors acetylcholinesterase — the cleft's enzyme sculpting the signal's ~1-ms duration.